About Sensyne
Life Sciences
What we do
Build & Protect
We build large datasets of de-identified and anonymised patient data in collaboration with health systems, providing an important source of clinical information for research while safeguarding patient privacy.
Curate & Analyse
We curate and analyse the datasets using algorithms.
Identify & Discover
We use machine learning to discover new insights that will support life sciences research and development.
The way we work
The Sensyne Life Sciences team combines clinical and data science expertise to develop machine learning technologies applied to ethically sourced de-identified and anonymised patient data analysed from our partnerships with health systems, and clinical trial data from Sensyne’s partnership with Phesi Inc.
To further develop Sensyne’s life sciences capability, we are building SENSIGHT™ a world class pharmaceutical research and development platform to accelerate the speed of data processing, analysis and insight discovery.
Sensyne was able to overdeliver in terms of data collected, while sticking to the initial timeline. It was a very fruitful collaboration, and thanks to Sensyne capabilities, we have been able to get meaningful clinical information from a large cohort of UK patients.
Life sciences activities focus on applying machine learning across the medicinal R&D process to:
Improve
Improve clinical trials by distinguishing specific groups of patients and Identifying sub-sets of responders and non-responders.
Understand
Understand the mechanism of disease in the real world in order to personalise treatment plans and coherently diagnose sufferers of poorly understood diseases.
Predict
Predict clinical events earlier such as stroke or heart failure.
Discover
Discover new treatments faster to address unmet medical needs.
For healthcare systems
We work collaboratively with public healthcare systems, such as the UK’s NHS, US-based health systems and other healthcare organisations around the world in a trusted ethical partnership. Our partners receive a commercial return in the form of equity and/or IT investment and a share of Sensyne revenues, that can be reinvested back into patient care and medical research.
For life science organisations
In response to specific questions that our life sciences partners ask, Sensyne analyse patient and clinical trial data and share the insights, not the data itself, from that analysis which enables pharmaceutical companies to use the insights to develop targeted drugs with a higher chance of success.
The current medical discovery system involves interpreting enormous volumes of diverse information. It can be like finding a needle in a haystack, without knowing what a needle is, what a needle looks like or where the haystack is. We aim to change that.
Our focus
Drug discovery
- Target ID
- Target validation
Clinical trial optimisation
- Patient stratification
- Synthetic control arms
- Analytics combining clinical trial and real world data
- Event prediction
Market access
- Health economic outcomes research
- Outcomes based pricing
- Post launch research and monitoring
No ordinary job
We’re looking for people who share our collective passion for solving healthcare’s biggest challenges.
Join our team
